OFFICE LEASEOffice Lease • February 25th, 2020 • Kura Oncology, Inc. • Pharmaceutical preparations
This Office Lease (this “Lease”), dated January 8, 2020, by and between BRE CA OFFICE OWNER LLC, a Delaware limited liability company (“Landlord”), and KURA ONCOLOGY, INC., a Delaware corporation (“Tenant”). The following exhibits are incorporated herein and made a part hereof: Exhibit A (Outline of Premises); Exhibit A-1 (Legal Description of Property); Exhibit B (Expenses and Taxes); Exhibit C (Work Letter); Exhibit D (Form of Confirmation Letter); Exhibit E (Rules and Regulations); Exhibit F (Additional Provisions); and Exhibit G (Judicial Reference).
Kura Oncology, Inc.Kura Oncology, Inc. • February 25th, 2020 • Pharmaceutical preparations • California
This letter sets forth the terms of the separation agreement (the “Agreement”) that Kura Oncology, Inc. (the “Company”) is offering to you to aid in your employment transition.
